ARA-290 is supplied as a lyophilized powder and is intended strictly for laboratory research applications.

ARA-290 is a synthetic research peptide engineered from the B-helix domain of erythropoietin. In experimental models, it selectively binds the EPOR–CD131 receptor complex, activating the innate repair receptor (IRR) pathway without stimulating erythropoiesis.

Preclinical investigations utilize ARA-290 to study cytokine modulation, endothelial barrier integrity, neuroimmune signaling mechanisms, inflammatory pathway regulation, and tissue protection models.

For laboratory research use only. Not for human consumption. Not intended for diagnostic, therapeutic, or clinical applications.